We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




Compact Immunoassay and Clinical Chemistry Analyzer Helps Low- to Mid-Volume Labs Tackle Challenges

By LabMedica International staff writers
Posted on 21 Jul 2023

Clinical laboratories face crucial operational challenges that hinder productivity, such as an increased number of patient samples, staff shortages, and additional documentation requirements. More...

Now, a new immunoassay and clinical chemistry testing system is designed to address these issues related to labor shortages, while also promoting revenue growth and enhancing agility beyond standardization and clinical equivalence. Workflow improvements offered by this system can aid laboratories in achieving more predictable turnaround times, reducing reporting duties, and allowing staff to concentrate on essential lab operations.

Every lab, irrespective of its size, grapples with significant challenges arising from labor shortages. These range from ensuring reliable test results to facilitating predictable care, protecting staff, securing data, and achieving environmental objectives. The Atellica CI Analyzer from Siemens Healthineers (Erlangen, Germany) enables both standalone labs and satellite labs of wider health networks to access the same reagents, consumables, and intelligent software as the company's flagship Atellica Solution, but now in a compact 1.9 square meters footprint ideal for smaller laboratories. Labs with low to medium testing volumes will appreciate the competitive edge offered by the Atellica CI Analyzer, including improved turnaround time predictability, advanced reporting functionality, and robust safety and security measures.

Designed with standout capabilities, the Atellica CI Analyzer maximizes downtime usage and bolsters lab efficiency and profitability. Features like random access sampling, micro-volume aspiration, and automatic scheduling for maintenance and quality control enable labs to deliver more predictable sample turnaround times. The independent operation of chemistry and immunoassay engines ensures that throughput isn't compromised if one of the two needs to be halted. In addition to producing patient results, labs also need to meet reporting requirements, address cybersecurity, and achieve staff satisfaction goals. The Atellica CI Analyzer comes with the Atellica Laboratory Evaluation Suite to provide inspection-ready reports, helping labs meet accreditation guidelines without requiring additional software and allowing laboratory staff to redirect their efforts toward other important lab operations. Increased security measures are also available, including user authentication, role-based authorizations, and audit trails. With a planned menu of over 200 assays spanning 20 disease states, each lab in a health network can select the best tests for its patient population, fulfilling clinical needs that might otherwise be unmet. More than 50 key assays can produce results in less than 14 minutes.

"Workflow standardization and clinical equivalence are critical components of a successful laboratory operation within a health network. The Atellica CI Analyzer elevates laboratory operations to a new level of agility," said Sharon Bracken, head of Diagnostics for Siemens Healthineers. "Labs today need testing instrumentation and informatics that can easily keep pace with rapidly changing testing demands as they occur. This next-generation laboratory analyzer anticipates workflow bottlenecks, mitigates them proactively, and delivers insights based on data that help laboratory staff do their job more effectively and efficiently."

Related Links:
Siemens Healthineers 


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test utilizes mtDNA biomarkers to detect molecular signatures associated with endometriosis (Photo courtesy of Shutterstock)

Endometriosis Blood Test Could Replace Invasive Laparoscopic Diagnosis

Endometriosis affects an estimated 1 in 10 women globally, yet diagnosis can take 7 to 10 years on average due to the invasive nature of laparoscopy and lack of accurate, non-invasive tests.... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.